An De Groef1, Marijke Van Kampen2, Elena Tieto2, Petra Schönweger2, Marie-Rose Christiaens3, Patrick Neven4, Inge Geraerts2, Nick Gebruers5, Nele Devoogdt2. 1. KU Leuven - University of Leuven, Department of Rehabilitation Sciences and University Hospitals Leuven, Department of Physical Medicine and Rehabilitation, Belgium. Electronic address: an.degroef@faber.kuleuven.be. 2. KU Leuven - University of Leuven, Department of Rehabilitation Sciences and University Hospitals Leuven, Department of Physical Medicine and Rehabilitation, Belgium. 3. Multidisciplinary Breast Centre, University Hospitals Leuven, Leuven, Belgium; KU Leuven - University of Leuven, Oncology Department, Department of Surgical Oncology, Belgium. 4. Multidisciplinary Breast Centre, University Hospitals Leuven, Leuven, Belgium; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium. 5. Univeristy of Antwerp, Faculty of Medicine and Health Sciences, Department of Rehabilitation Sciences and Physiotherapy, Antwerp, Belgium.
Abstract
PURPOSE: The aim of this study is (1) to investigate the prevalence rate of arm lymphedema, pain, impaired shoulder range of motion, strength and shoulder function one year after a sentinel lymph node biopsy (SLNB) for breast cancer and (2) to determine predictive factors for these complications. METHODS: A longitudinal study was performed. One hundred patients with a sentinel-lymph node negative breast cancer were included. All patients were measured before surgery and one year after. Arm lymphedema was measured with the perimeter, pain with the Visual Analogue Scale, shoulder range of motion with an inclinometer, strength with a handheld dynamometer and shoulder function with the Disability of Arm, Shoulder and Hand questionnaire. Patient-, breast cancer- and treatment-related variables were recorded. RESULTS: One year after surgery 8% of sentinel node-negative breast cancer patients had developed arm lymphedema. Fifty percent of patients had pain, 30% had an impaired shoulder range of motion, 8% had a decreased handgrip strength and 49% had an impaired shoulder function. Pain, shoulder range of motion, strength and shoulder dysfunctions changed significantly over one year (p < 0.001). Higher Body Mass Index is a predictive variable for shoulder dysfunctions one year post-SLNB. CONCLUSIONS: Prevalence rate of lymphedema and other upper limb impairments may not be underestimated after SLNB. Pain, shoulder range of motion, handgrip strength and shoulder function change significantly up to one year compared to preoperative values in sentinel node-negative breast cancer patients.
PURPOSE: The aim of this study is (1) to investigate the prevalence rate of arm lymphedema, pain, impaired shoulder range of motion, strength and shoulder function one year after a sentinel lymph node biopsy (SLNB) for breast cancer and (2) to determine predictive factors for these complications. METHODS: A longitudinal study was performed. One hundred patients with a sentinel-lymph node negative breast cancer were included. All patients were measured before surgery and one year after. Arm lymphedema was measured with the perimeter, pain with the Visual Analogue Scale, shoulder range of motion with an inclinometer, strength with a handheld dynamometer and shoulder function with the Disability of Arm, Shoulder and Hand questionnaire. Patient-, breast cancer- and treatment-related variables were recorded. RESULTS: One year after surgery 8% of sentinel node-negative breast cancerpatients had developed arm lymphedema. Fifty percent of patients had pain, 30% had an impaired shoulder range of motion, 8% had a decreased handgrip strength and 49% had an impaired shoulder function. Pain, shoulder range of motion, strength and shoulder dysfunctions changed significantly over one year (p < 0.001). Higher Body Mass Index is a predictive variable for shoulder dysfunctions one year post-SLNB. CONCLUSIONS: Prevalence rate of lymphedema and other upper limb impairments may not be underestimated after SLNB. Pain, shoulder range of motion, handgrip strength and shoulder function change significantly up to one year compared to preoperative values in sentinel node-negative breast cancerpatients.
Authors: Thais Cristina Siqueira; Simone Pedrozo Frágoas; Andreia Pelegrini; Ana Rosa de Oliveira; Clarissa Medeiros da Luz Journal: Support Care Cancer Date: 2020-08-17 Impact factor: 3.603
Authors: Paulo Furtado de Oliveira; Ricardo da Silva Alves; Denise Hollanda Iunes; Jovana Maria de Carvalho; Juliana Bassalobre Carvalho Borges; Flávia da Silva Menezes; Leonardo César Carvalho Journal: Games Health J Date: 2020-02-21
Authors: Helena Harder; Patrick Holroyd; Lynn Burkinshaw; Phil Watten; Charles Zammit; Peter R Harris; Anna Good; Val Jenkins Journal: J Cancer Surviv Date: 2017-07-24 Impact factor: 4.442
Authors: Beatriz Ostos-Díaz; María Jesús Casuso-Holgado; María Jesús Muñoz-Fernández; Ana F Carazo; Rocío Martín-Valero; Esther M Medrano-Sánchez Journal: Int J Environ Res Public Health Date: 2020-11-12 Impact factor: 3.390